Heaton K M, el-Naggar A, Ensign L G, Ross M I, Balch C M
Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston.
Ann Surg. 1994 Feb;219(2):197-204. doi: 10.1097/00000658-199402000-00012.
Forty-six cases of subungual melanoma were reviewed to identify significant clinicopathologic prognostic factors, determine the role of DNA content analysis in the biologic assessment of these tumors, and evaluate the effectiveness of amputation level, lymph node dissection (LND), and regional limb perfusion on the survival of these patients.
Subungual melanoma is a unique and rare subtype of melanoma, constituting only 1% to 3% of cases. Thus, little is known about prognostic factors and optimal management of patients with this disease. Moreover, the appropriate level of amputation and LND and limb perfusion in the management of subungual melanoma remain controversial.
Forty-six patients underwent amputation alone or in combination with LND and/or regional limb perfusion for primary subungual melanoma. The effects of these treatment modalities and the prognostic significance of patient and tumor-related variables, including DNA flow cytometric data, on overall survival were assessed.
Univariate statistical analysis identified six factors that significantly affected patient survival. They were stage at diagnosis (p = 0.0001), percentage of aneuploid cells (p = 0.01), presence of ulceration (p = 0.02) or bone invasion (p = 0.02), thickness of the primary lesion (p = 0.03), and percentage of cells in S-phase (p = 0.03). Multivariate analyses identified tumor stage and S-phase fraction as independent prognostic factors in these patients. Survival did not differ among patients who received amputation alone or those who underwent amputation in combination with LND or perfusion (p = 0.90); however, the use of limb perfusion reduced the incidence of locally recurrent disease. The level of amputation did not affect patient survival (p = 0.74) or the incidence of local recurrence.
The study identified several significant prognostic factors, including DNA flow cytometric parameters, in patients with subungual melanoma. In addition, it showed that conservative amputation of the affected digit at the level of the proximal interphalangeal or metacarpophalangeal/metatarsophalangeal joint appears to be safe, provided that clear margins are obtained. Although isolated limb perfusion may reduce the incidence of local recurrence, LND, or limb perfusion in the routine management of subungual melanoma remains controversial.
回顾46例甲下黑色素瘤病例,以确定重要的临床病理预后因素,确定DNA含量分析在这些肿瘤生物学评估中的作用,并评估截肢水平、淋巴结清扫(LND)和区域肢体灌注对这些患者生存的有效性。
甲下黑色素瘤是黑色素瘤一种独特且罕见的亚型,仅占病例的1%至3%。因此,对于该疾病患者的预后因素和最佳治疗知之甚少。此外,甲下黑色素瘤治疗中截肢和LND以及肢体灌注的合适水平仍存在争议。
46例患者因原发性甲下黑色素瘤单独接受截肢或联合LND和/或区域肢体灌注治疗。评估了这些治疗方式以及患者和肿瘤相关变量(包括DNA流式细胞术数据)对总生存的预后意义。
单因素统计分析确定了六个显著影响患者生存的因素。它们是诊断时的分期(p = 0.0001)、非整倍体细胞百分比(p = 0.01)、溃疡存在(p = 0.02)或骨侵犯(p = 0.02)、原发灶厚度(p = 0.03)以及S期细胞百分比(p = 0.03)。多因素分析确定肿瘤分期和S期分数是这些患者的独立预后因素。单独接受截肢的患者与接受截肢联合LND或灌注的患者生存无差异(p = 0.90);然而,肢体灌注的使用降低了局部复发疾病的发生率。截肢水平不影响患者生存(p = 0.74)或局部复发发生率。
该研究确定了甲下黑色素瘤患者的几个重要预后因素,包括DNA流式细胞术参数。此外,研究表明,只要获得切缘阴性,在近端指间关节或掌指/跖趾关节水平对患指进行保守截肢似乎是安全的。虽然孤立肢体灌注可能降低局部复发率,但LND或肢体灌注在甲下黑色素瘤常规治疗中的作用仍存在争议。